ProCE Banner Activity

Strategies for Managing AEs and Promoting Adherence to CDK4/6 Inhibitors

Slideset

Expert-curated downloadable slideset on managing adverse events and promoting adherence to CDK4/6 inhibitors in the treatment for patients with HR-positive/HER2-negative metastatic breast cancer.

Released: October 04, 2024

Expiration: October 03, 2025

Share

Faculty

Elizabeth Diaz

Elizabeth Diaz, PA-C

Physician Assistant
Medical Oncology
UT Health San Antonio MD Anderson Cancer Center
San Antonio, Texas

Provided by

Provided by Partners for Advancing Clinical Education (PACE) in partnership with Practicing Clinicians Exchange, LLC and Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Lilly and Novartis Pharmaceuticals Corporation.

Lilly

Novartis Pharmaceuticals Corporation

Partners

Clinical Care Options, LLC

ProCE Banner

Practicing Clinicians Exchange

ProCE Banner